Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase NA 1Phase 2/3 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Carcinoma, Lobular 1Breast Neoplasms 1

Interventions

Specimen Handling 278pembrolizumab 228Magnetic Resonance Spectroscopy 228Carboplatin 180Biopsy 168Cisplatin 166Nivolumab 160Cyclophosphamide 144Radiotherapy 126Paclitaxel 124Gemcitabine 116Bevacizumab 96durvalumab 92Dexamethasone 88Rituximab 81Oxaliplatin 80venetoclax 75atezolizumab 74Capecitabine 71Fluorouracil 70Docetaxel 70Doxorubicin 68Etoposide 65Radiosurgery 64Ipilimumab 64Radiation 62Prednisone 61Cytarabine 60Lenalidomide 58Pemetrexed 55

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Positron Emission Tomography Computed Tomography × 90 days × Clear all
NCT06067503 2026-04-13

Biomarkers to Detect Endocrine Therapy Resistance

University of Wisconsin, Madison

Phase 2 Recruiting
8 enrolled
Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡